Related references
Note: Only part of the references are listed.Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
Matias Autio et al.
HAEMATOLOGICA (2021)
Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma
David D. W. Twa et al.
BLOOD (2021)
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL
Annette M. Staiger et al.
LEUKEMIA (2020)
Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis
Rebecca L. King et al.
VIRCHOWS ARCHIV (2020)
Combined chemotherapy and radiotherapy improves survival in 1897 testicular Lymphoma patients from a contemporary cohort
Fernando Caumont et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Adverse prognostic impact of regulatory T-cells in testicular diffuse large B-cell lymphoma
Marjukka Pollari et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Low Absolute Lymphocyte Counts in the Peripheral Blood Predict Inferior Survival and Improve the International Prognostic Index in Testicular Diffuse Large B-Cell Lymphoma
Pauli Vahamurto et al.
CANCERS (2020)
TBL1XR1 mutation predicts poor outcome in primary testicular diffuse large B-cell lymphoma patients
Xinfeng Wang et al.
BIOMARKER RESEARCH (2020)
Molecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma
Leo Meriranta et al.
BLOOD ADVANCES (2020)
The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma
Stefan Hatzl et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma
Suvi-Katri Leivonen et al.
HAEMATOLOGICA (2019)
PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype
James Godfrey et al.
BLOOD (2019)
Chimeric Antigen Receptor-Engineered T Cell Therapy in Lymphoma
Paolo Strati et al.
CURRENT ONCOLOGY REPORTS (2019)
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
Ziju Y. Xu-Monette et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Genetic alterations and their clinical implications in DLBCL
Yi Miao et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
Takahiro Kamada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
Huizhong Xiong et al.
CANCER IMMUNOLOGY RESEARCH (2019)
High frequency of inactivating tetraspanin CD37 mutations in diffuse large B-cell lymphoma at immune-privileged sites
Suraya Elfrink et al.
BLOOD (2019)
Intravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma
S. Mannisto et al.
EUROPEAN JOURNAL OF CANCER (2019)
Expression of programmed cell death-ligand 1 in primary testicular diffuse large B cell lymphoma: A retrospective study
Dongdong Zhu et al.
ONCOLOGY LETTERS (2019)
Prevalence And Clinical Significance Of Oncogenic CD79B And MYD88 Mutations In Primary Testicular Diffuse Large B-Cell Lymphoma: A Retrospective Study In China
Yan-ping Chen et al.
ONCOTARGETS AND THERAPY (2019)
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study
Stephen M. Ansell et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Primary testicular lymphoma: A SEER analysis of 1,169 cases
Haitao Xu et al.
ONCOLOGY LETTERS (2019)
The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies
David D. W. Twa et al.
BLOOD REVIEWS (2018)
Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization
Binghe Tan et al.
CANCER RESEARCH (2018)
A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance
Joerg Huelsken et al.
CELL (2018)
Cancer-Associated Fibroblasts Affect Intratumoral CD8+ and FoxP3+ T Cells Via IL6 in the Tumor Microenvironment
Takuya Kato et al.
CLINICAL CANCER RESEARCH (2018)
PD-L1(+) tumor-associated macrophages and PD-1(+) tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma
Marjukka Pollari et al.
HAEMATOLOGICA (2018)
Metformin's antitumour and anti-angiogenic activities are mediated by skewing macrophage polarization
Ji-Chang Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response
Eric Ubil et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
R. Schmitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Proton irradiation orchestrates macrophage reprogramming through NF kappa B signaling
Geraldine Genard et al.
CELL DEATH & DISEASE (2018)
Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
David Wang et al.
CELL REPORTS (2018)
PD-L1(+) tumor-associated macrophages and PD-1(+) tumor-infiltrating lymphocytes predict survival in primary testicular lymphoma
Marjukka Pollari et al.
HAEMATOLOGICA (2018)
The role of Foxp3 and Tbet co-expressing Treg cells in lung carcinoma
Katerina Kachler et al.
ONCOIMMUNOLOGY (2018)
Microenvironment Cell Contribution to Lymphoma Immunity
Deepika Kumar et al.
FRONTIERS IN ONCOLOGY (2018)
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma
Ranjana Advani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era
Robert Kridel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
The significance of FOXP1 in diffuse large B-cell lymphoma
Duncan M. Gascoyne et al.
LEUKEMIA & LYMPHOMA (2017)
CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness
Tomasz Ahrends et al.
IMMUNITY (2017)
Efficacy of prophylactic irradiation to the contralateral testis for patients with advanced-stage primary testicular lymphoma: an analysis of outcomes at a single institution
Ryouji Tokiya et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Clinical Impact of the Cell-of-Origin Classification and the MYC/BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
Annette M. Staiger et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma
Jennifer C. Ho et al.
LEUKEMIA & LYMPHOMA (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Vaccines targeting helper T cells for cancer immunotherapy
Marit Meissen et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Tomasz Maj et al.
NATURE IMMUNOLOGY (2017)
Exhaustion of T lymphocytes in the tumor microenvironment: Significance and effective mechanisms
Mohammad Davoodzadeh Gholami et al.
CELLULAR IMMUNOLOGY (2017)
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Anupama Reddy et al.
CELL (2017)
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma
Lakshmi Nayak et al.
BLOOD (2017)
Beyond the lymph nodes: FDG-PET/CT in primary extranodal lymphoma
Kin Man Sin et al.
CLINICAL IMAGING (2017)
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy et al.
BLOOD (2016)
MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis
Shaoying Li et al.
HISTOPATHOLOGY (2016)
Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium
L. Deng et al.
LEUKEMIA (2016)
Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma
Qing Ye et al.
ONCOTARGET (2016)
Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
U. Vitolo et al.
ANNALS OF ONCOLOGY (2016)
Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
Kerry J. Savage et al.
BLOOD (2016)
Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas
Lauren C. Chong et al.
BLOOD (2016)
Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy
Hiromichi Takahashi et al.
LEUKEMIA & LYMPHOMA (2016)
MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study
Christiane Copie-Bergman et al.
BLOOD (2015)
Immune checkpoint inhibition in lymphoid disease
Toby A. Eyre et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
NF-κB Regulates PD-1 Expression in Macrophages
Alexander P. R. Bally et al.
JOURNAL OF IMMUNOLOGY (2015)
Recurrent genomic rearrangements in primary testicular lymphoma
David D. W. Twa et al.
JOURNAL OF PATHOLOGY (2015)
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wyndham H. Wilson et al.
NATURE MEDICINE (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
High prevalence of the MYD88 mutation in testicular lymphoma: Immunohistochemical and genetic analyses
Naoki Oishi et al.
PATHOLOGY INTERNATIONAL (2015)
Cancer and the Immune System: Basic Concepts and Targets for Intervention
Drew Pardoll
SEMINARS IN ONCOLOGY (2015)
Overcoming T cell exhaustion in infection and cancer
Kristen E. Pauken et al.
TRENDS IN IMMUNOLOGY (2015)
The role of invariant natural killer T cells in dendritic cell licensing, cross-priming, and memory CD8+ T cell generation
Catherine Gottschalk et al.
FRONTIERS IN IMMUNOLOGY (2015)
Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial
Sari Riihijarvi et al.
HAEMATOLOGICA (2015)
Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) Is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated With PDCD1LG2 Copy Gain
Min Shi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Zheng Zhou et al.
BLOOD (2014)
MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab
Anamarija M. Perry et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Double hit lymphoma: the MD Anderson Cancer Center clinical experience
Yasuhiro Oki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Phenotype profiling of primary testicular diffuse large B-cell lymphomas
Thomas Menter et al.
HEMATOLOGICAL ONCOLOGY (2014)
RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance
Yanping Xiao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma
W. Kraan et al.
LEUKEMIA (2014)
An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone
Soo Jeong Nam et al.
LEUKEMIA & LYMPHOMA (2014)
MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Li-Xu Yan et al.
PLOS ONE (2014)
The tumour microenvironment in B cell lymphomas
David W. Scott et al.
NATURE REVIEWS CANCER (2014)
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
Heike Horn et al.
BLOOD (2013)
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
Shimin Hu et al.
BLOOD (2013)
Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era?
Lijuan Deng et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
T-bet: a bridge between innate and adaptive immunity
Vanja Lazarevic et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Molecular Characterization of Immunoglobulin Gene Rearrangements in Diffuse Large B-Cell Lymphoma Antigen-Driven Origin and IGHV4-34 as a Particular Subgroup of the Non-GCB Subtype
Elena Sebastian et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Pathogenesis of Human B Cell Lymphomas
Arthur L. Shaffer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab
Nalan Akyurek et al.
CANCER (2012)
CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1
Julien Fourcade et al.
CANCER RESEARCH (2012)
Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience
Mette O. Pedersen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Tina Marie Green et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Nathalie A. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The Blood-Testis and Blood-Epididymis Barriers Are More than Just Their Tight Junctions
Payal Mital et al.
BIOLOGY OF REPRODUCTION (2011)
Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Gonzalo Gutierrez-Garcia et al.
BLOOD (2011)
First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial
Umberto Vitolo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab
Paul N. Meyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses
Lucy S. K. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2011)
B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma
Matija Snuderl et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
Jang-June Park et al.
BLOOD (2010)
Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response
Riad Abes et al.
BLOOD (2010)
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Mark P. Chao et al.
CELL (2010)
Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab
Sharon Barrans et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+ B-Cell Lymphoma in the Rituximab Era
Marita Ziepert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Outcome of patients with diffuse large B-cell lymphoma of the testis by era of treatment: the M. D. Anderson Cancer Center experience
Ali Mazloom et al.
LEUKEMIA & LYMPHOMA (2010)
Primary testicular diffuse large B-cell lymphoma shows an activated B-cell-like phenotype
Dan Li et al.
PATHOLOGY RESEARCH AND PRACTICE (2010)
Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a vaccinal effect of rituximab
Shannon P. Hilchey et al.
BLOOD (2009)
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
Nathalie A. Johnson et al.
BLOOD (2009)
A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
William W. L. Choi et al.
CLINICAL CANCER RESEARCH (2009)
Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations
Naoto Tomita et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome
Maria Grazia Tibiletti et al.
HUMAN PATHOLOGY (2009)
Primary Testicular Diffuse Large B-Cell Lymphoma: A Population-Based Study on the Incidence, Natural History, and Survival Comparison With Primary Nodal Counterpart Before and After the Introduction of Rituximab
Jacob D. Gundrum et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
M2 Macrophages phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro
Marzia Leidi et al.
JOURNAL OF IMMUNOLOGY (2009)
Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP
Heidi Nyman et al.
MODERN PATHOLOGY (2009)
Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations
N. Niitsu et al.
LEUKEMIA (2009)
Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses
Ye Zheng et al.
NATURE (2009)
The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation
Meghan A. Koch et al.
NATURE IMMUNOLOGY (2009)
Rituximab and Dose-Dense Chemotherapy in Primary Testicular Lymphoma
Agustin Aviles et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways
M. Booman et al.
JOURNAL OF PATHOLOGY (2008)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Macrophage polarization in tumour progression
Antonio Sica et al.
SEMINARS IN CANCER BIOLOGY (2008)
Mechanisms of killing by anti-CD20 monoclonal antibodies
Martin J. Glennie et al.
MOLECULAR IMMUNOLOGY (2007)
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses
Manish J. Butte et al.
IMMUNITY (2007)
Altered macrophage differentiation and immune dysfunction in tumor development
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
Laurie H. Sehn et al.
BLOOD (2007)
Conventional T-bet+Foxp3- Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection
Dragana Jankovic et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Drug Insight: the mechanism of action of rituximab in autoimmune disease - the immune complex decoy hypothesis
Ronald P. Taylor et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases
Mousa A. Al-Abbadi et al.
MODERN PATHOLOGY (2006)
Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics
M. Booman et al.
JOURNAL OF PATHOLOGY (2006)
Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphoma
M Booman et al.
CLINICAL CANCER RESEARCH (2006)
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation)
SK Biswas et al.
BLOOD (2006)
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions
LM Rimsza et al.
BLOOD (2006)
Distinct role of macrophages in different tumor microenvironments
CE Lewis et al.
CANCER RESEARCH (2006)
High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis
SA Riemersma et al.
JOURNAL OF PATHOLOGY (2005)
Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self
S Sakaguchi
NATURE IMMUNOLOGY (2005)
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
S Monti et al.
BLOOD (2005)
Testicular lymphoma - A retrospective, population-based, clinical and immunohistochemical study
S Hasselblom et al.
ACTA ONCOLOGICA (2004)
The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy
JJ Uchida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
CP Hans et al.
BLOOD (2004)
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
G Wright et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Complement activation determines the therapeutic activity of rituximab in vivo
N Di Gaetano et al.
JOURNAL OF IMMUNOLOGY (2003)
Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment
EJ Wherry et al.
JOURNAL OF VIROLOGY (2003)
β2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system
ES Jordanova et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group
E Zucca et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system
ES Jordanova et al.
GENES CHROMOSOMES & CANCER (2002)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
An oncological view on the blood-testis barrier
J Bart et al.
LANCET ONCOLOGY (2002)
Primary large-cell non-Hodgkin's lymphoma of the testis: A retrospective analysis of patterns of failure and prognostic factors
JF Seymour et al.
CLINICAL LYMPHOMA (2001)
Non-Hodgkin's lymphoma of the testis: A retrospective study of 84 patients treated in the French anticancer centres
JL Lagrange et al.
ANNALS OF ONCOLOGY (2001)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Autocrine production of IL-10 mediates defective IL-12 production and NF-κB activation in tumor-associated macrophages
A Sica et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
